TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

PharmaNet Development Group Inc. (NASDAQ: PDGI) Investor Investigation Over Proposed Acquisition. What Do You Think? Vote Here

  • If you purchased PharmaNet Development Group (NASDAQ: PDGI), you have certain options. You should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

PharmaNet Development Group, Inc. (Nasdaq: PDGI), a leading provider of clinical development services, today announced that it has signed a definitive merger agreement with affiliates of JLL Partners, Inc. to purchase all of the outstanding shares of PharmaNet at a price of $5.00 per share in cash. According to a press release an investigation on behalf of PharmaNet Development Group,...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: